Clinical trial
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
NCT07898943 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- January 31, 2029
- Enrollment
- 1,600 (estimated)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast surgery, surgical site infection (ssi), surgical site infection prevention
Lead sponsor's other trials
University Hospital, Clermont-Ferrand, most recent start first.
+853 more trials See the organization page
Similar trials
Same condition (Surgical Wound Infection) and phase, most recent start first.
+68 more trials See the condition page